Do Myelin Oligodendrocyte Glycoprotein Antibodies Represent a Distinct Syndrome?

John J. Chen, Clare L. Fraser

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Myelin oligodendrocyte glycoprotein (MOG-IgG) antibodies have been associated with a variety of demyelinating neurologic disorders, including optic neuritis. It remains unclear whether the presence of MOG-IgG represents a distinct syndrome or is simply a marker for central demyelination. Two experts, John J. Chen, MD, PhD, and Clare L. Fraser, MBBS, MMed, debate this topic.

Original languageEnglish (US)
Pages (from-to)416-423
Number of pages8
JournalJournal of Neuro-Ophthalmology
Volume39
Issue number3
DOIs
StatePublished - Sep 1 2019

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Do Myelin Oligodendrocyte Glycoprotein Antibodies Represent a Distinct Syndrome?'. Together they form a unique fingerprint.

Cite this